 Immunologic parameters early-stage HIV-seropositive subjects vaccine responsiveness asymptomatic HIV-seropositive subjects HIV-seronegative controls serologic response live viral protein toxoid vaccine antigens Extensive vivo vitro immunologic evaluations Factors immunogen responsiveness HIV-seropositive patients vaccine responses results T- B-cell functional assays Eleven HIV-seropositive patients HIV vaccines analysis meningococcus group diphtheria-tetanus normals immunogens HIV-seropositive patients HIV responsive-R normals HIV NR group distinctive immunologic abnormalities poor immunogen responsiveness defects T-cell helper function normalization cell number defective T-cell suppression Epstein-Barr virus EBV vitro HIV NR suppression HIV suppression normals suppression EBV-driven immunoglobulin production vitro cells HIV NR groups abnormal vivo HIV NR patients cells native response B-cell growth factor increased thymidine incorporation HIV-NR cpm HIV normal HIV NR/HIV HIV NR/N